Sign in

CIK 0001321834 · Non-accelerated filer<br>Smaller reporting company

Q/C TECHNOLOGIES, INC.

Sign in to watch
Ticker
QCLS
Exchange
Nasdaq
Industry
In Vitro & In Vivo Diagnostic Substances
FY end
Dec 31
Incorporated
DE
Entity type
operating
Phone
856-848-8698
Business address
1185 AVENUE OF THE AMERICAS, SUITE 249, NEW YORK, NY, 10036
Former names
Q/C TECHNOLOGIES, INC., TNF Pharmaceuticals, Inc., MyMD Pharmaceuticals, Inc., Akers Biosciences, Inc., Akers Biosciences Inc
  1. CORRESP Other Correspondence Between Filers and SEC Staff
  2. S-3 Offering Registration Statement
  3. UPLOAD Other SEC-generated Letter
  4. 424B3 Offering Prospectus
  5. CORRESP Other Correspondence Between Filers and SEC Staff
  6. S-3 Offering Registration Statement
  7. UPLOAD Other SEC-generated Letter
  8. CORRESP Other Correspondence Between Filers and SEC Staff
  9. UPLOAD Other SEC-generated Letter
  10. UPLOAD Other SEC-generated Letter
  11. CORRESP Other Correspondence Between Filers and SEC Staff
  12. UPLOAD Other SEC-generated Letter
  13. 424B3 Offering Prospectus
  14. CORRESP Other Correspondence Between Filers and SEC Staff
  15. S-3/A Offering Registration Statement
  16. UPLOAD Other SEC-generated Letter
  17. S-3 Offering Registration Statement
  18. 424B5 Offering Prospectus
  19. 424B5 Offering Prospectus
  20. 424B3 Offering Prospectus

Page 1 of 6 · 110 filings